The Cancer Tumor Profiling Market is expected to reach USD 31.99 Billion by 2027, according to a new report by Emergen Research. This market’s growth is attributed to the increasing use of biomarkers in cancer profiling, eventually rising adoption of proteomic methods for biomarker research, thus helping to increase the drug development process over the estimated period. The growing demand for personalized medicine and the rise in cancer incidence across the globe is augmenting the demand for the industry. According to the World Health Organization (WHO), Lung and Breast cancer is a common type of cancer, with around 2.09 million cases every year. The growing demand for cancer tumor profiling is driving the market for the estimated period.
The rise in the adoption of the cancer tumor profiling methods by oncologists is seen to drive the market because of the efficacy of cancer tumor profiling for diagnosis at the early stage of cancer, which is one factor in boosting the market growth. However, technical issues with sample collection and storage remain one of the factors that hinder the growth of the market for the forecast period.
The report is refurbished with the impact of the COVID-19 pandemic on the global Cancer Tumor Profiling market. The pandemic and subsequent social restrictions have dynamically changed the market and impacted the economic scenario of the market through disruptions in the supply chains, financial difficulties, and changes in the demands and trends of the industry. Moreover, a shift in consumer behavior has also affected the Cancer Tumor Profiling industry. The report provides an in-depth impact analysis of the pandemic on the market to better understand the latest changes in the market and gain a futuristic outlook on a post-COVID-19 scenario.
To get a sample copy of the global Graphene market report, visit @ https://www.emergenresearch.com/request-sample/50
Competitive Outlook:
The latest research report offers key insights into the strengths and weaknesses of the prominent players using SWOT and Porter’s Five Forces analyses. Market segmentation based on product type, application spectrum, and key regions has been included in the report. The investigative study accurately estimates the market size, market share, and revenue generation over the projected timeframe. The key players profiled in the report are Caris Life Sciences, Foundation Medicine, GenomeDX, Genomic Health, Guardant Health, Helomics Corporation, HTG Molecular Diagnostics, Inc., Nanostring Technologies, Neogenomics Inc., Oxford Gene Technology, Qiagen N.V., Ribomed Biotechnologies Inc., among others.
Market Segmentation:
Emergen Research have segmented the Cancer Tumor Profiling Market on the basis of technique type, technology, application, and region:
Technique Type Outlook (Revenue, USD Billion; 2017-2027)
Genomics
Epigenetics
Metabolomics
Proteomics
Technology Outlook (Revenue, USD Billion; 2017-2027)
Immunoassays
In Situ Hybridization
Fluorescence In Situ Hybridization (FISH)
Chromogenic In Situ Hybridization (CISH)
Microarray
Polymerase Chain Reaction (PCR)
Sequencing Technologies
Next Generation Sequencing(NGS)
Pyro Sequencing
Sanger Sequencing
Other Technologies
Application Outlook (Revenue, USD Billion; 2017-2027)
Research Application
Biomarker Discovery
Personalized Cancer Medicine
Clinical Application
Oncological Diagnostics
Prognostics
Monitoring and Treatment
Screening
To get the report at an incredible discount, visit @ https://www.emergenresearch.com/request-discount/50
Some Key Highlights from the Report
The Genomics segment was valued at 2.76 Billion in 2019, owing to the rise in the research institutes’ funding for developing modified medicine is expected to increase the demand for the genomics industry. The use of genomics technology by various companies for cancer tumor profiling is anticipated to increase the overall genomics industry’s demand for the upcoming forecast period.
Asia Pacific countries such as China, India, and Japan, have seen a striking increase in cancer tumor profiling. Developing economies, including India, Singapore, and Korea, are anticipated to intensify global demand.
High investments by companies to launch new products for cancer tumor profiling with various advancement in the new technique is augmented to propel the market. For instance, in May 2019, QIAGEN, launched therascreen PIK3CA RGQ PCR Kit as a companion diagnostic to aid in identifying breast cancer patients.
Immunoassays segments are seen to have the largest market share in 2019. The Immunoassays technology is used to detect tumors with applications in Oncological Diagnostics, Prognostics, Monitoring and Treatment, and Screening.
Key Objectives of the Global Cancer Tumor Profiling Market Report:
An all-inclusive analysis and forecast estimation of the market have been included in this report.
The report offers valuable insights into the major drivers, limitations, opportunities, and challenges faced by the global Cancer Tumor Profiling market and its leading players.
The report sheds light on the prominent market contenders, as well as their business strategies and long-term expansion plans.
Key Regions Studied in the Report:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
In conclusion, the report provides a qualitative and quantitative analysis of the Global Cancer Tumor Profiling market including the global and regional analysis of the market. The study covers critical information and factual data about the Cancer Tumor Profiling market industry, along with an in-depth statistical analysis of the market drivers, limitations, growth prospects, opportunities, and threats. On the basis of the current market scope, the report provides an extensive analysis of how the Cancer Tumor Profiling market is expected to fare in the forecast timeline. The report utilizes advanced analytical tools to offer an estimation of the outlook of the global state of the Cancer Tumor Profiling market industry.
Request a customized copy of report @ https://www.emergenresearch.com/request-for-customization/50
Thank you for reading our report. For further details or to inquire about the customization of the report, please reach out to our team. We will offer you the report as per your requirements.
Take a Look at our Related Reports:
Free Space Optics (FSO) Communication Technology Market
AI-Enabled Medical Imaging Solutions Market
Intelligent Drug Discovery Market
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting
Read Press Release@ https://www.emergenresearch.com/press-release/global-cancer-tumor-profiling-market